(19)
(11)EP 2 958 990 A1

(12)

(43)Date of publication:
30.12.2015 Bulletin 2015/53

(21)Application number: 14754746.7

(22)Date of filing:  20.02.2014
(51)International Patent Classification (IPC): 
C12N 5/07(2010.01)
C12N 5/00(2006.01)
C12N 5/10(2006.01)
C12N 5/02(2006.01)
(86)International application number:
PCT/US2014/017452
(87)International publication number:
WO 2014/130706 (28.08.2014 Gazette  2014/35)
(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30)Priority: 20.02.2013 US 201361767093 P

(71)Applicant: Regeneron Pharmaceuticals, Inc.
Tarrytown, NY 10591 (US)

(72)Inventors:
  • LEE, Jeffrey, D.
    New York New York 10025 (US)
  • AUERBACH, Wojtek
    Ridgewood New Jersey 07450 (US)
  • HESLIN, David
    Closter New Jersey 07624 (US)
  • FRENDEWEY, David
    New York New York 10016 (US)
  • LAI, Ka-man Venus
    Tarrytown New York 10591 (US)
  • VALENZUELA, David M.
    Yorktown Heights, New York 10598 (US)

(74)Representative: Hutter, Anton et al
Venner Shipley LLP 200 Aldersgate
London EC1A 4HD
London EC1A 4HD (GB)

  


(54)GENETIC MODIFICATION OF RATS